What is CONTINUUMRX?
ContinuumRx is a specialized provider of home and site-based infusion therapies and services, dedicated to supporting patient care and recovery. With over two decades of operational experience, the company collaborates with healthcare systems to optimize post-acute care coordination and management. Their extensive service portfolio includes antibiotic therapy, enteral and parenteral nutrition, IVIG therapy, heart failure therapy, and biologic therapies. ContinuumRx's commitment to high-quality care is validated by its accreditation from the Accreditation Commission for Health Care (ACHC).
How much funding has CONTINUUMRX raised?
CONTINUUMRX has raised a total of $21.5M across 3 funding rounds:
Unspecified
$7M
Private Equity
$13.5M
Debt
$1M
Unspecified (2012): $7M with participation from Mitsui & Co, Health Enterprise Partners, Stonehenge Capital, and Redmont Venture Partners
Private Equity (2015): $13.5M led by NewSpring Capital
Debt (2020): $1M supported by PPP
Key Investors in CONTINUUMRX
Mitsui & Co
Mitsui & Co. is a global trading and investment company with a diverse portfolio across multiple industries, focusing on creating long-term sustainable value through collaboration and cross-industry expertise. They are involved in supplying resources, promoting energy transition, and enhancing quality of life through healthcare solutions.
Health Enterprise Partners
HEP Fund is a strategic investment firm that partners with organizations transforming the healthcare industry, providing capital and strategic advice to drive innovation in healthcare delivery.
Stonehenge Capital
Stonehenge Capital is a tax-credit service, venture capital, and investment firm established in 1999, focused on supporting businesses through various investment strategies.
What's next for CONTINUUMRX?
The recent major strategic investment into ContinuumRx signals a strong confidence in its business model and its capacity for expansion within the home infusion therapy market. This capital infusion is likely to fuel further development of its service offerings, enhance its technological infrastructure for better patient management, and potentially broaden its geographic reach. The company's focus on partnering with healthcare systems to improve post-acute care coordination positions it well for growth, especially as the demand for efficient and patient-centric healthcare solutions continues to rise. ContinuumRx's strategic backing will enable it to solidify its market position and pursue new opportunities in an evolving healthcare landscape.
See full CONTINUUMRX company page
